Skip to main content

Comparative study of selective in vitro and in silico BACE1 inhibitory potential of glycyrrhizin together with its metabolites, 18α- and 18β-glycyrrhetinic acid, isolated from Hizikia fusiformis

Abstract

Hizikia fusiformis (Harvey) Okamura is a brown seaweed widely used in Korea and Japan, and it contains different therapeutically active constituents. In the present study, we investigated the activities of glycyrrhizin isolated from H. fusiformis, including its metabolites, 18α- and 18β-glycyrrhetinic acid against Alzheimer’s disease (AD) via acetyl and butyrylcholinesterase and β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibition. Among these three compounds, 18β-glycyrrhetinic acid (IC50 = 8.93 ± 0.69 µM) demonstrated two fold potent activity against BACE1 compared to the positive control, quercetin (IC50 = 20.18 ± 0.79 µM). Additionally, glycyrrhizin with an IC50 value of 20.12 ± 1.87 µM showed similarity to quercetin, while 18α-glycyrrhetinic acid showed moderate activity (IC50 = 104.35 ± 2.84 µM). A kinetic study revealed that glycyrrhizin and 18β-glycyrrhetinic acid were non-competitive and competitive inhibitiors of BACE1, demonstrated via Ki values of 16.92 and 10.91 µM, respectively. Molecular docking simulation studies evidently revealed strong binding energy of these compounds for BACE1, indicating their high affinity and capacity for tighter binding to the active site of the enzyme. These data suggest that glycyrrhizin isolated from the edible seaweed, H. fusiformis and its metabolite, 18β-glycyrrhetinic acid demonstrated selective inhibitory activity against BACE1 to alleviate AD.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  • Akao T (1998) Distribution of enzymes involved in the metabolism of glycyrrhizin in various organs of rat. Biol Pharm Bull 21:1036–1044

    CAS  Article  Google Scholar 

  • Akao T, Akao T, Hattori M, Kanaoka M, Yamamoto K, Namba T, Kobashi K (1991) Hydrolysis of glycyrrhizin to 18β-glycyrrhetyl monoglucuronide by lysosomal β-d-glucuronidase of animal livers. Biochem Pharmacol 41:1025–1029

    CAS  Article  Google Scholar 

  • Ali MY, Seong SH, Reddy MR, Seo SY, Choi JS, Jung HA (2017) Kinetics and molecular docking studies of 6-formyl umbelliferone isolated from Angelica decursiva as an inhibitor of cholinesterase and BACE1. Molecules 22:1604

    Article  Google Scholar 

  • Asl MN, Hosseinzadeh H (2008) Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22:709–724

    CAS  Article  Google Scholar 

  • Alzheimer’s Association (2017) Alzheimer’s disease facts and figures. Alzheimers Dement 13:325–373

    Article  Google Scholar 

  • Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW (2003) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361:2045–2046

    CAS  Article  Google Scholar 

  • Damle M (2014) Glycyrrhiza glabra (Liquorice)—a potent medicinal herb. Int J Herb Med 2:132–136

    Google Scholar 

  • Ellman GL, Courtney KD, Andres VJ, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholineserase activity. Biochem Pharmacol 7:88–95

    CAS  Article  Google Scholar 

  • Eteghad SS, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J (2014) Amyloid-beta: a crucial factor in Alzheimer’s disease. Med Princ Pract 24:1–10

    Article  Google Scholar 

  • Farag MA, Porzel A, Wessjohann LA (2012) Comparative metabolite profiling and fingerprinting of medicinal licorice roots using a multiplex approach of GC–MS, LC–MS and 1D NMR techniques. Phytochemistry 76:60–72

    CAS  Article  Google Scholar 

  • Fenwick GR, Lutomski J, Nieman C (1990) Liquorice, Glycyrrhiza glabra L.—composition, uses and analysis. Food Chem 38:119–143

    CAS  Article  Google Scholar 

  • Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D (2005) A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol 99:317–324

    Article  Google Scholar 

  • Folch J, Petrov D, Ettcheto M, Abad S, Sanchez-Lopez E, Garcia ML, Camins Espuny A (2016) Current research therapeutic strategies for Alzheimer’s disease treatment. Neural Plast 2016:1–15

    Article  Google Scholar 

  • Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137–147

    CAS  Article  Google Scholar 

  • Geldenhuys WJ, Darvesh AS (2015) Pharmacotherapy of Alzheimer’s disease: current and future trends. Expert Rev Neurother 15:3–5

    CAS  Article  Google Scholar 

  • Han YR, Ali M, Woo MH, Jung HA, Choi JS (2015) Anti-diabetic and anti-inflammatory potential of the edible brown alga Hizikia fusiformis. J Food Biochem 39:417–428

    CAS  Article  Google Scholar 

  • Hardy J (2009) The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal. J Neurochem 110:1129–1134

    CAS  Article  Google Scholar 

  • Huh GW, Lee DY, In SJ, Lee DG, Park SY, Yi TH, Baek NI (2012) Fucosterols from Hizikia fusiformis and their proliferation activities on osteosarcoma-derived cell MG63. J Korean Soc Appl Biol Chem 55:551–555

    CAS  Article  Google Scholar 

  • Ishida T, Mizushina Y, Yagi S, Irino Y, Nishiumi S, Miki I, Kondo Y, Mizuno S, Yoshida H, Azuma T, Yoshida M (2012) Inhibitory effects of glycyrrhetinic acid on DNA polymerase and inflammatory activities. Evid Based Complement Alternat Med 2012:1–9

    Article  Google Scholar 

  • Jung BM, Ahn CB, Kang SJ, Park JH, Chung DH (2001) Effects of Hijikia fusiforme extracts on lipid metabolism and liver antioxidative enzyme activities in triton-induced hyperlipidemic rats. J Korean Soc Food Sci Nutr 30:1184–1189

    CAS  Google Scholar 

  • Jung HA, Ali MY, Choi RJ, Jeong HO, Chung HY, Choi JS (2016) Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera. Food Chem Toxicol 89:104–111

    CAS  Article  Google Scholar 

  • Karawita R, Siriwardhana N, Lee KW, Heo MS, Yeo IK, Lee YD, Jeon YJ (2005) Reactive oxygen species scavenging, metal chelation, reducing power and lipid peroxidation inhibition properties of different solvent fractions from Hizikia fusiformis. Eur Food Res Technol 220:363–371

    CAS  Article  Google Scholar 

  • Khan R, Khan AQ, Lateef A, Rehman MU, Tahir M, Ali F, Hamiza OO, Sultana S (2013) Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats. PLoS ONE 8:e56020

    CAS  Article  Google Scholar 

  • Kim KI (1998) Studies on the blood anticoagulant polysaccharide isolated from hot water extracts of Hizikia fusiforme. J Food Sci Nutr 27:1204–1210

    Google Scholar 

  • Kim JH, Morgan AM, Tai BH, Van DT, Cuong NM, Kim YH (2016) Inhibition of soluble epoxide hydrolase activity by compounds isolated from the aerial parts of Glycosmis stenocarpa. J Enzyme Inhib Med Chem 31:640–644

    CAS  Article  Google Scholar 

  • Koo JG, Choi YS, Kwak JK (2001) Blood-Anticoagulant Activity of Fucoidans from Sporophylls of Undaria pinnatifida, Laminaria religiosa, Hizikia fusiforme and Sargassum fulvellum in Korea. J Koreran Fish Soc 34:511–520

    Google Scholar 

  • Kurz A, Perneczky R (2011) Novel insights for the treatment of Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 35:373–379

    CAS  Article  Google Scholar 

  • Langer D, Czarczynska-Goslinska B, Goslinski T (2016) Glycyrrhetinic acid and its derivatives in infectious diseases. Curr Issues Pharm Med Sci 29:118–123

    CAS  Article  Google Scholar 

  • Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658–666

    CAS  Article  Google Scholar 

  • Link P, Wetterauer B, Fu Y, Wink M (2015) Extracts of Glycyrrhiza uralensis and isoliquiritigenin counteract amyloid-β toxicity in Caenorhabditis elegans. Planta Med 81:357–362

    CAS  Article  Google Scholar 

  • Luo L, Jin Y, Kim ID, Lee JK (2013) Glycyrrhizin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. Exp Neurobiol 22:107–115

    Article  Google Scholar 

  • Ma Z, Wu M, Lin L, Thring RW, Yu H, Zhang X, Zhao M (2017) Allelopathic interactions between the macroalga Hizikia fusiformis (Harvey) and the harmful blooms-forming dinoflagellate Karenia mikimotoi. Harmful Algae 65:19–26

    Article  Google Scholar 

  • Mizoguchi K, Kanno H, Ikarashi Y, Kase Y (2014) Specific binding and characteristics of 18β-glycyrrhetinic acid in rat brain. PLoS ONE 9:e95760

    Article  Google Scholar 

  • Pang SJ, Chen LT, Zhuang DG, Fei XG, Sun JZ (2005) Cultivation of the brown alga Hizikia fusiformis (Harvey) Okamura: enhanced seedling production in tumbled culture. Aquaculture 245:321–329

    Article  Google Scholar 

  • Park KE, Jang MS, Lim CW, Kim YK, Seo YW, Park HY (2005) Antioxidant activity on ethanol extract from boiled-water of Hizikia fusiformis. J Korean Soc Appl Biol Chem 48:435–439

    Google Scholar 

  • Schelterns P, Feldman H (2003) Treatment of Alzheimer’s disease; current status and new perspectives. Lancet Neurol 2:539–547

    Article  Google Scholar 

  • Seeman P, Seeman N (2011) Alzheimer’s disease: β-amyloid plaque formation in human brain. Synapse 65:1289–1297

    CAS  Article  Google Scholar 

  • Sen S, Roy M, Chakraborti AS (2011) Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. J Pharm Pharmacol 63:287–296

    CAS  Article  Google Scholar 

  • Shao ZQ (2015) Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer’s disease. Int J Clin Exp Med 8:2944–2948

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sugimoto H (2008) The new approach in development of anti-Alzheimer’s disease drugs via the cholinergic hypothesis. Chem Biol Interact 175:204–208

    CAS  Article  Google Scholar 

  • Sung MW, Li PC (2004) Chemical analysis of raw, dry-roasted, and honey-roasted licorice by capillary electrophoresis. Electrophoresis 25:3434–3440

    CAS  Article  Google Scholar 

  • Takeda S, Ishihara K, Wakui Y, Amagaya S, Maruno M, Akao T, Kobashi K (1996) Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis. J Pharm Pharmacol 48:902–905

    CAS  Article  Google Scholar 

  • Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, Jiang T, Zhu XC, Tan L (2014) Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 41:615–631

    CAS  Article  Google Scholar 

  • Tolstikov GA, Baltina LA, Serdyuk NG (1998) Glycyrrhetic acid (a review). Pharma Chem J 32:402–412

    Article  Google Scholar 

  • Wang Z, Kurosaki Y, Nakayama T, Kimura T (1994) Mechanism of gastrointestinal absorption of glycyrrhizin in rats. Biol Pharm Bull 17:1399–1403

    CAS  Article  Google Scholar 

  • Wu M, Tong C, Wu Y, Liu S, Li W (2016) A novel thyroglobulin-binding lectin from the brown alga Hizikia fusiformis and its antioxidant activities. Food Chem 201:7–13

    CAS  Article  Google Scholar 

  • Yamamura Y, Kawakami J, Santa T, Kotaki H, Uchino K, Sawada Y, Iga T (1992) Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method. J Pharm Sci 81:1042–1046

    CAS  Article  Google Scholar 

  • Zhao K, Ding M, Cao H, Cao ZX (2012) In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates. J Pharm Pharmacol 64:1445–1451

    CAS  Article  Google Scholar 

  • Zou D, Gao K, Ruan Z (2006) Seasonal pattern of reproduction of Hizikia fusiformis (Sargassaceae, Phaeophyta) from Nanao Island, Shantou, China. J Appl Phycol 18:195–201

    Article  Google Scholar 

Download references

Acknowledgements

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2012R1A6A1028677).

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Hyun Ah Jung or Jae Sue Choi.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wagle, A., Seong, S.H., Zhao, B.T. et al. Comparative study of selective in vitro and in silico BACE1 inhibitory potential of glycyrrhizin together with its metabolites, 18α- and 18β-glycyrrhetinic acid, isolated from Hizikia fusiformis. Arch. Pharm. Res. 41, 409–418 (2018). https://doi.org/10.1007/s12272-018-1018-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-018-1018-2

Keywords

  • Hizikia fusiformis
  • 18β-glycyrrhetinic acid
  • glycyrrhizin
  • 18α-glycyrrhetinic acid
  • BACE1